Interpace Biosciences, Inc. ( IDXG) - Stock Earnings
IDXG Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
IDXG Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -1.6 million USD | 8.3 million USD |
| 2023Q1 | 351000 USD | 9.8 million USD |
| 2023Q2 | 175000 USD | 11.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
IDXG Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -26.5 million USD | 32.4 million USD |
| 2021 | -14.9 million USD | 41.3 million USD |
| 2022 | -22.0 million USD | 31.8 million USD |
| 2025 Est. | — | — |
IDXG
Price: $6.50
Earnings Per Share: -0.66 USD
P/E Ratio: -2.70
Exchange: OQX
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1193
Ebitda: -2.5 millionMarket Capitalization: 33.4 million